Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Mallinckrodt
Daiichi Sankyo
AstraZeneca
QuintilesIMS
Moodys
Accenture
Citi
Baxter

Generated: April 22, 2018

DrugPatentWatch Database Preview

Lorcaserin hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for lorcaserin hydrochloride and what is the scope of lorcaserin hydrochloride patent protection?

Lorcaserin hydrochloride
is the generic ingredient in two branded drugs marketed by Eisai Inc and is included in two NDAs. There are fifteen patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Lorcaserin hydrochloride has one hundred and seventy-six patent family members in forty-one countries.

There are five drug master file entries for lorcaserin hydrochloride. One supplier is listed for this compound.
Summary for lorcaserin hydrochloride
Pharmacology for lorcaserin hydrochloride
Synonyms for lorcaserin hydrochloride
(1R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride
(1R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepinium chloride
(1R)-8-Chloro-2,3,4,5-tetrahydro-1-methyl-1H-3-benzazepine hydrochloride
(5R)-7-chloro-5-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride
(R)-1h-3-benzazepine,8-chloro-2,3,4,5-tetrahydro-1-methyl-,hydrochloride
(R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride
(r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine hydrochloride salt
(R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-benzo[d]azepine hydrochloride
(R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-benzo[d]azepine hydrochloride hemihydrate
0QJF08GDPE
846589-98-8
AB0080320
AC-8945
ACT10402
AK142745
AKOS005145786
AN-7508
AOB87116
APD-356
BC224447
BCP9000859
Belviq
Belviq (TN)
Belviq Xr
CHEBI:65350
CHEMBL2095211
CS-0752
D06613
DTXSID60233650
EX-A1697
FT-0696346
HY-15368
ITIHHRMYZPNGRC-QRPNPIFTSA-N
KS-0000006Z
KS-1439
Lorcaserin (Hydrochloride)
Lorcaserin HCl
Lorcaserin hydrochloride (USAN)
Lorcaserin hydrochloride [USAN]
Lorcaserin hydrochloride(APD-356)
Lorqess
MFCD09833667
MolPort-005-942-404
QC-9041
SCHEMBL173899
ST24035516
UNII-0QJF08GDPE
W-5408

US Patents and Regulatory Information for lorcaserin hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Eisai Inc BELVIQ XR lorcaserin hydrochloride TABLET, EXTENDED RELEASE;ORAL 208524-001 Jul 15, 2016 RX Yes Yes ➤ Sign Up ➤ Sign Up Y Y ➤ Sign Up
Eisai Inc BELVIQ lorcaserin hydrochloride TABLET;ORAL 022529-001 Jun 27, 2012 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Eisai Inc BELVIQ lorcaserin hydrochloride TABLET;ORAL 022529-001 Jun 27, 2012 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Eisai Inc BELVIQ XR lorcaserin hydrochloride TABLET, EXTENDED RELEASE;ORAL 208524-001 Jul 15, 2016 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents for lorcaserin hydrochloride

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,846,906 5HT.sub.2C receptor modulators ➤ Sign Up
8,404,675 Benzazepine derivatives and methods of prophylaxis or treatment of 5HT2C receptor associated diseases ➤ Sign Up
8,993,750 5HT.sub.2C receptor modulators ➤ Sign Up
7,704,993 Benzazepine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Baxter
Fish and Richardson
Deloitte
Argus Health
Julphar
Queensland Health
Chinese Patent Office
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.